AQR Capital Management’s OptiNose OPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-2,855
Closed -$133K 2301
2021
Q2
$133K Buy
2,855
+1,817
+175% +$92.8K ﹤0.01% 2174
2021
Q1
$57K Buy
+1,038
New +$63.1K ﹤0.01% 2168
2020
Q4
Sell
-943
Closed -$55K 2243
2020
Q3
$55K Buy
+943
New +$69.8K ﹤0.01% 2167

Other funds holding OPTN

AQR Capital Management's OPTN Position: Q3 2021 in Review

AQR Capital Management sold out of OptiNose (OPTN) in Q3 2021, closing a stake of 2,855 shares — an estimated $133K sold.

AQR Capital Management first reported a position in OPTN in Q3 2020 and held it in 3 quarters. The position peaked at $133K in Q2 2021. 49 funds tracked by Wall St. Rank hold OPTN as of Q3 2021.

  • AQR Capital Management reported no remaining OptiNose position as of Q3 2021 after selling out during the quarter.
  • AQR Capital Management sold 2,855 OptiNose shares in Q3 2021, an estimated $133K.
  • AQR Capital Management first reported a position in OptiNose in Q3 2020 and held it in 3 quarters.
  • AQR Capital Management's OptiNose position peaked at $133K in Q2 2021.
  • 49 funds tracked by Wall St. Rank held OptiNose as of Q3 2021.

Based on AQR Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.